期刊文献+

大肠癌对顺铂、5-氟尿嘧啶、羟基喜树碱的敏感性与P-糖蛋白表达的研究 被引量:3

Research of primary drug resistance of colorectal carcinoma to hydroxycamptothecin?cisplatin and 5-fluorouracil、with corelation of It's p-glycoprotein expression
下载PDF
导出
摘要 目的 探讨大肠癌对羟基喜树碱 (HCPT)、顺铂 (CDDP)、5 氟尿嘧啶 (5 Fu)的敏感性与P 糖蛋白 (P gp)表达之间的相关性。方法 MTT法检测 37例大肠癌细胞的药物敏感性 ,流式细胞技术 (FCM )检测其P gp表达 ,数据按中效原理计算。 结果 大肠癌对CDDP、5 Fu单药或加CDDP的敏感性与P gp表达阳性率增加而降低 ;而对HCPT单药或加CDDP或 5 Fu的高敏、中敏、不敏感各组间P gp表达无明显差别。大肠癌的耐药系娄在HCPT的CDDP或 5 Fu联用时降低 ,但在CDDP与 5 Fu联用时增加。结论 大肠癌对CDDP、5 Fu的敏感性与P gp表达程度呈负相关 ,而对HCPT的敏感性与P gp表达无明显相关性。HCPT与CDDP或 5 Fu联用对大肠癌的抑制有协同作用 ,而 5 Fu +CDDP则达不到协同或相加作用。 Objective To evaluate the the correlation between the percentage of P gp positive cells and the sensitivity of colorectal carcinoma cells to hydroxycamptothecin?cisplatin and 5 Fluorouracil.Methods Flow cytometry (FCM) was used to detect P gp, and MTT to assay the sensitivity to chemotherapeutics. The median effect principle was used to calculate the concentration(μmol/ml) of single drug and two drug combination when 50% of cancer cells were inhibited (LC50). Results The sensitivity of colorectal cancer cells to 5 Fu?CDDP or 5 Fu+CDDP decreased while their P gp expression increased,but their P gp expression almost had no different among the arms of high?middle and non sensitivity.Conclusion The sensitivity of colorectal carcinoma to CDDP?5 Fu correlated reversely with the percentage of P gp positive cells,but didn′t correlated to HCPT.The use of HCPT plus CDDP or 5 Fu achieved synergetic action to suppress the colorectal cancer cells,but 5 Fu plus CDDP didn′t achieved synergetic action. Key words:colorectal carcinoma;p glycoprotein; hydroxycamptothecin; cisplatin; 5 fluorouracil
出处 《重庆医学》 CAS CSCD 2003年第2期152-154,共3页 Chongqing medicine
  • 相关文献

参考文献3

二级参考文献4

共引文献12

同被引文献42

  • 1胡利民,姜民,王少峡,高秀梅,张伯礼.合成冰片对大鼠肝CYP450酶含量及CYP3A1 mRNA表达的影响[J].天津中医药,2005,22(4):284-286. 被引量:12
  • 2辛华雯.CYP3A4和P糖蛋白与药物的肠道处置[J].中国临床药理学与治疗学,2005,10(7):721-725. 被引量:3
  • 3李伟荣,董静,宓穗卿,王宁生.复方丹参滴丸对大鼠肝微粒体细胞色素P450含量的影响[J].中成药,2005,27(9):1092-1093. 被引量:16
  • 4杨润祥,马飞.奥沙利铂的神经毒性及其防治[J].中国医学文摘(肿瘤学),2005,19(3):248-249. 被引量:9
  • 5Rothenberg ML,Oza AM,Bigelow RH,Berlin JD,Marshall JL,Ramanathan RK,Hart LL,Gupta S,Garay CA,Burger BG,Le Bail N,Haller DG.Superiority of oxaliplatin and fluorouracilleucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin:interim results of a phase Ⅲ trial.J Clin Oncol 2003; 21:2059-2069
  • 6Rougier P,Lepille D,Bennouna J,Marre A,Ducreux M,Mignot L,Hua A,Mery-Mignard D.Antitumour a ctivity of three second-line treatment combinationsin patients with metastatic colorectal cancer after optimal 5-FU regimen failure:a randomised,multicentre phase Ⅱ study.Ann Oncol 2002; 13:1558-1567
  • 7Miller AB,Hoogstraten B,Staquet M,Winkler A.Reporting results of cancer treatment.Cancer 1981;47:207-214
  • 8O'Dwyer PJ,Johnson SW.Current status of oxaliplatin in colorectal cancer.Semin Oncol 2003;30:78-87
  • 9Maindrault-Goebel F,de Gramont A,Louvet C,Andre T,Carola E,Gilles V,Lotz JP,Tournigand C,Mabro M,Molitor JL,Artru P,Izrael V,Krulik M.Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer.Oncology Multidisciplinary Research Group (GERCOR).Ann Oncol 2000; 11:1477-1483
  • 10Zhang R,Li Y,Cai Q,Liu T,Sun H,Chambless B.Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I.Cancer Chemother Pharmacol 1998; 41:257-267

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部